Lucy Wills

Patient‐reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life

Joyce E. Wilkinson, T. Peters, P. Fayers, 2016, BJU international.

Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)

Catherine J. Grey, Susan N Moore, P. Fayers, 2022, Bju International.

Toward semi-automated assessment of target volume delineation in radiotherapy trials: the SCOPE 1 pretrial test case.

J. Staffurth, E. Spezi, T. Crosby, 2012, International journal of radiation oncology, biology, physics.

The effect of planning algorithms in oesophageal radiotherapy in the context of the SCOPE 1 trial.

J. Staffurth, T. Crosby, A. Millin, 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy

Rhydian Maggs, John Staffurth, J. Staffurth, 2017, Radiation Oncology.

Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy

J. Staffurth, T. Crosby, L. Nixon, 2017, Radiation oncology.

Inter-observer variation in outlining of pre-trial test case in the SCOPE1 trial: A United Kingdom definitive chemoradiotherapy trial for esophageal cancer

J. Staffurth, E. Spezi, T. Crosby, 2011 .